Please use this identifier to cite or link to this item:
|Scopus||Web of Science®||Altmetric|
|Title:||Trends over 5 years in cardiovascular medicine use in Australian veterans with diabetes|
|Citation:||British Journal of Clinical Pharmacology, 2007; 64(1):100-104|
|Publisher:||Blackwell Publishing Ltd|
|Roughead, Elizabeth E.; Pratt, Nicole; Gilbert, Andrew L.|
|Abstract:||<h4>Aim</h4>To determine trends over 5 years in cardiovascular medicine use in the Australian veteran population with diabetes.<h4>Methods</h4>An observational study. All veterans dispensed medicines indicative of diabetes between 2000 and 2005 were identified from the Veterans Affairs pharmacy claims dataset. Concurrent dispensings of angiotensin-converting enzyme inhibitor (ACEI), lipid-lowering medicines and antiplatelets were assessed.<h4>Results</h4>ACEI/angiotensin II receptor blocker use has risen from 46% to 67% in the veteran population dispensed medicines indicative of diabetes. Lipid-lowering medicines have increased from 33% to 58% and antiplatelets from 28% to 50%.<h4>Conclusion</h4>The increasing use of cardiovascular medicines in the diabetes population is suggestive of improved treatment practices over time, consistent with guidelines and quality use of medicines initiatives.|
|Keywords:||ACE inhibitors; antiplatelet; cardiovascular; diabetes; drug utilisation; lipid lowering therapy|
|Description:||The definitive version is available at www.blackwell-synergy.com|
|Appears in Collections:||Public Health publications|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.